- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 20.06. | A longer 'winter': Public funding slowdown heightens pressure on biotech startups | ||
| 20.06. | Gene therapy faces fresh uncertainty as two more top FDA officials depart | ||
| 18.06. | FDA approves twice-yearly shot of Gilead drug for HIV prevention | ||
| 18.06. | Scholar Rock drug preserves muscle in obesity trial | ||
| 18.06. | Draig, a brain drug startup, debuts with $140M to treat depression | ||
| 18.06. | FDA to speed reviews for drugs supporting 'national interests' | ||
| 18.06. | A startup banks $66M to pursue 'inclusive precision medicine' | ||
| 17.06. | Lilly to acquire Verve in $1B bet on gene editing for heart disease | ||
| 17.06. | FDA clears CSL's swelling disease drug; Regeneron loses 23andMe auction | ||
| 16.06. | Could the FDA take an indirect approach to regulate lab developed tests? | ||
| 16.06. | Roche, waving off study failures, commits to Phase 3 trials for Parkinson's drug | ||
| 16.06. | Sage, following Setbacks, to sell to Supernus for $561M | ||
| 16.06. | FDA to miss approval deadline for Kalvista drug due to 'resource constraints' | ||
| 13.06. | Novo, searching for a spark, plans late-stage trials for amylin drug | ||
| 13.06. | Moderna wins FDA OK to widen use of RSV vaccine | ||
| 13.06. | AstraZeneca forms an AI deal in China; Third Harmonic advances liquidation plans | ||
| 12.06. | BioNTech buys mRNA, courtroom rival CureVac in all-stock deal | ||
| 12.06. | RFK Jr. reveals picks for influential vaccine panel | ||
| 12.06. | Pharma's wins and losses in the budget bill | ||
| 11.06. | SpliceBio lands $135M for a new kind of eye gene therapy | ||
| 11.06. | Bristol Myers bolsters radiopharma portfolio with PhiloChem deal | ||
| 11.06. | Insmed surges on lung drug data; Recursion cuts staff | ||
| 10.06. | Scorpion, fresh off Lilly deal, spins out startup Antares | ||
| 10.06. | Vaccine makers face fresh uncertainty after firing of CDC panel | ||
| 10.06. | National Resilience, a well-funded manufacturing startup, to scale back operations |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .